| Product NDC: | 0173-0453 |
| Proprietary Name: | FLONASE |
| Non Proprietary Name: | Fluticasone Propionate |
| Active Ingredient(s): | 50 ug/1 & nbsp; Fluticasone Propionate |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0453 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020121 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19941108 |
| Package NDC: | 0173-0453-01 |
| Package Description: | 1 BOTTLE in 1 CARTON (0173-0453-01) > 120 SPRAY, METERED in 1 BOTTLE |
| NDC Code | 0173-0453-01 |
| Proprietary Name | FLONASE |
| Package Description | 1 BOTTLE in 1 CARTON (0173-0453-01) > 120 SPRAY, METERED in 1 BOTTLE |
| Product NDC | 0173-0453 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluticasone Propionate |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 19941108 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FLUTICASONE PROPIONATE |
| Strength Number | 50 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |